0
FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.
(Visited 1 times, 1 visits today)
Related posts:
Trump supporters line up at Miami-Dade GOP headquarters on day of Biden’s inauguration
Parents charged in Broward crash that killed 1-year-old son
Ice cream shop owner in Coral Springs stalks, harasses teenage girl, police say
Family members mourn loss of man killed in collision with Brightline train
Suspects held without bond after ex-Hialeah cop accused of beating handcuffed man